🔗 Share this article

MND impacts nerve cells found in the brain and spine, that instruct your muscles how to function.

This leads them to weaken and stiffen over time and typically impacts how you walk, speak, consume food and respire.

It is a quite uncommon disease that is most common in people above age fifty, but adults of all ages can be impacted.

An individual's lifetime risk of developing MND is one in 300.

About five thousand people in the UK will have the disease at any given moment.

Scientists are not sure what causes MND, but it is likely to be a combination of the genes - or biological traits - you get from your mother and father when you are delivered, and other environmental influences.

For up to 10% of people with MND, specific genes play a much larger role.

Typically there is a family history of the illness in such instances.

Identifying the First Signs of the Disease?

MND impacts each person uniquely.

Not everyone has the identical signs, or encounters them in the same order.

The condition can advance at varying rates too.

Among the most common indicators are:

• loss of muscle strength and cramps
• stiff joints
• problems with your speech
• complications involving ingesting, eating and drinking
• reduced cough reflex

Does There Exist a Cure?

No cure, but there is hope stemming from therapies targeted at various types of MND.

MND is not one disease - it is actually multiple that result in the death of motor neurones.

A new drug called tofersen works in only one in 50 patients, however it has been demonstrated to decelerate - and in certain instances even reverse - some of the symptoms of MND.

It has been referred to as "truly remarkable" and a "significant point of hope" for the whole disease.

Even though the medication has recently been approved in the European Union, it is not currently accessible in the UK.

There is only one pharmaceutical currently licensed for the management of MND in the UK and endorsed by the NHS.

Riluzole may slow down the progression of the disease and prolong life by a few months, but it cannot repair damage.

Determining Survival Rate for MND?

Certain individuals can survive for decades with MND, including theoretical physicist Stephen Hawking, who was diagnosed at the age of 22 and survived until 76.

But for most, the illness progresses quickly and survival time is just a few years.

Based on the charity MND Association, the condition kills a one-third of people within a twelve months and more than half within two years of identification.

As the neurons cease functioning, ingestion and breathing become more challenging and many people need nutritional support or breathing apparatus to help them stay alive.

Do Sports Professionals At Greater Risk to Receive a Diagnosis?

The precise reason has not yet been found, but elite athletes seem overrepresented by MND.

Two studies from 2005 and 2009 showed that professional footballers have an elevated chance of contracting MND.

A 2022 study by the University of Glasgow including four hundred former Scotland rugby athletes determined they had an higher likelihood of acquiring the disease.

Researchers additionally discovered that rugby athletes who have experienced multiple concussions have physiological variations that could render them more susceptible to contracting MND.

The MND Association recognizes there is a "link" between collision sports and MND.

It added that while the athletes studied were had a greater chance to develop MND, it did not prove the athletic activities directly led to the condition.

The charity also emphasises that "reported MND instances in these studies is still relatively low, and so concluding there is a definite increased risk could be misinterpreted if this is merely a grouping due to random chance".

Multiple high-profile sports figures have been identified with the disease in recent years.

This encompasses former rugby internationals, footballers, and cricketers.

Across the Atlantic, MLB athlete Lou Gehrig died from the disease aged 39.